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Abstract: Background: Neck Pain (NP) is a common musculoskeletal disorder and the literature provides conflicting 
evidence about its management. 
Objective: To describe the methodology used to conduct an overview of reviews (OvR) and to characterize the 
distribution and risk of bias profiles across the evidence for all areas of NP management. 
Methods: Standard systematic review (SR) methodology was employed. MEDLINE, CINAHL, EMBASE, ILC, Cochrane 
CENTRAL, and LILACS were searched from 2000 to March 2012; Narrative and SR and clinical practice guidelines 
(CPG) evaluating the efficacy of treatment (benefits and harms), diagnosis/classification, prognosis, and outcomes were 
eligible. For treatment, articles were limited to SRs from 2005 forward. Risk of bias of SR was assessed with the 
AMSTAR; the AGREE II was used to critically appraise the CPGs. 
Results: From 2476 articles, 508 were eligible for full text screening. A total of 341 articles were included. Treatment 
(n=117) had the greatest yield. Other clinical areas had less literature (diagnosis=54, prognosis=16, outcomes=27, 
harms=16). There were no SR for classification and narrative reviews were problematic for this topic. There was great 
overlap across different databases within each clinical area except for those for outcome measures. Risk of bias 
assessment using the AMSTAR of eligible SRs showed a similar trend across different clinical areas. 
Conclusion: A summary of methods used to review the literature in five clinical areas of NP management have been 
described. The challenges of selecting and synthesizing eligible articles in an OvR required customized solutions across 
different areas of clinical focus. 
Keywords: Evidence syntheses, overview of reviews, neck pain. 
INTRODUCTION 
 The evidentiary base in some areas of musculoskeletal 
problems is sufficiently mature that a substantive number of 
systematic reviews (SRs) exist, particularly when the topic 
includes numerous interventions and patient groups. An 
overview of reviews (OvR) (often labeled as umbrella 
reviews or review of reviews) is one approach to 
summarizing large amounts of evidence by collating findings 
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from a series of SR [1]. OvR can be described as a relatively 
new approach to summarizing large amounts of evidence 
from SR in a single useful report, especially in areas where 
there are overlapping SR. Ideally, a SR will evaluate all 
relevant literature within a specific population for either 
interventions or other areas related to the management of the 
problem. Typically, SR will be limited to either a narrowly 
defined population or to a single intervention or comparator. 
Evaluation of a single SR may not provide a more global 
perspective that considers all populations likely to benefit 
from the intervention or compare across different 
interventions [2]. Additionally, SR evaluating the same or 
similar topics may present conflicting results; understanding 
why conclusions differ (or not) across SR and the 
implications of the discordance is becoming increasingly 
important for end users (clinicians, guideline developers, 
policymakers). One approach to address these issues is with 
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the undertaking of an OvR. Using methods similar to 
traditional SR, OvR attempt to identify high-quality, relevant 
SR and evaluate the consistency of findings across different 
reviews, thereby taking a more comprehensive approach to 
evaluating findings across different interventions, outcomes, 
adverse events, and patient populations [1, 2]. In some 
clinical areas, there are numerous existing SR and replication 
of already existing work within similar SR may not be 
efficient or ethical from a resource perspective [3]; 
undertaking an OvR would detect such overlap as well as 
areas where there are gaps. All these reasons reflect the 
growing need and increasing trend towards undertaking OvR 
that serve to provide a panorama view of evidence, 
particularly when the clinical questions are multifaceted and 
complex or summary across clinical management areas are 
considered. 
 In the context of managing neck pain (NP), an OvR 
would be ideal to provide an assessment of the evidentiary 
base across different clinical areas. NP has a high prevalence 
and has been associated with considerable disability and 
cost; for these reasons NP is considered an important 
musculoskeletal problem, particularly in industrialized 
countries [4]. NP can cause differing levels of pain and 
disability, resulting in impaired daily function, headaches, 
nerve-related problems (often radiating from the neck to the 
shoulder, arm, and hand) or cognitive disturbances [4]. The 
widespread frequency and recurrence of NP has led to 
hundreds of primary studies and reviews (both narrative and 
systematic) evaluating all aspects of clinical management of 
NP, including treatment, harms (associated with treatment), 
diagnosis, prevention, prognosis, and outcomes. The large 
and ever increasing literature base has provided a rich field 
of inquiry across which findings can be justifiably 
summarized. 
 This paper summarizes the methods used to prepare 
several OvR across five key clinical areas (treatment, harms, 
diagnosis/classification, prognosis, and outcomes) to assess 
the distribution and quality of the evidentiary basis. By 
providing evidence summaries in these key areas we hope to 
promote discussion and facilitate eventual agreement in the 
research community, and to inform future evidence-based 
recommendations for International Guidelines on the 
management of NP. The detailed findings for each area of 
clinical management of NP (treatment, harms, diagnosis, 
prognosis, and outcomes) are presented elsewhere (some in 
this same issue). However, in addition to describing the OvR 
methods used, the purpose is also to describe the relative 
distribution of the NP literature and the risk of bias profiles 
across the different areas of clinical management, which is 
one advantage of undertaking an OvR of this scope. 
METHODS 
 Standard SR methodology was employed with respect to 
searching for relevant articles and for SR selection, 
extraction, and risk of bias assessment. A literature search 
was undertaken from January 2000 to March 2012. Eligible 
articles included SR and clinical practice guidelines (CPG) 
for all five clinical areas of NP management. We included 
narrative reviews, consensus statements or commentaries for 
NP classification, diagnosis, prognosis, and outcomes. Not 
being certain of the number of relevant SR available, we 
hypothesized that key information might be available in 
narrative reviews (in the absence of SR) with respect to NP 
classification systems and outcome measures; we anticipated 
that these clinical areas may have less SR and also may be 
poorly indexed (for example, classification systems). For 
articles evaluating the efficacy of treatment in NP, we 
restricted the eligible studies to SR published from 2005 
forward due to the large volume of eligible reviews. This 
approach to restricting by year of publication for areas of 
greater activity is consistent with methods proposed when 
there are multiple similar SR; in this way the most 
chronologically recent and methodologically rigourous 
reviews would be screened when there is overlap with older 
SR [5]. 
Types of Participants in the Reviews and CPG 
 Articles had to include populations that had any type of 
NP to be eligible. The anatomical boundaries of the neck are 
defined as commencing from the occiput (base of the skull) 
to the upper thoracic spine (T1-T6, mid upper back) and can 
include the upper regions of the torso or shoulder area. The 
upper shoulder region is included within the definition 
because muscles attached to the neck are also attached as far 
as the lateral ends of the scapulae. Some articles included 
populations with general musculoskeletal or chronic pain 
that could potentially include NP; from these studies, only 
those that reported stratified data for NP, or some primary 
studies with NP or that included some primary studies with 
greater than 50% of NP patients in the sample, were eligible. 
Studies were limited to those that included adult participants 
(18 years or older) who complained of NP. 
 All types of non-malignant NP were eligible including 
both non-specific (no specific identifiable etiology) and 
specific groups. Non-specific NP is considered to have a 
postural or mechanical basis and includes whiplash 
associated disorders (WAD I to II), myofascial neck pain, 
degenerative changes, and cervicogenic headache 
(corresponding to diagnostic classification 11.2.1 proposed 
by the International Headache Society classification and 
diagnostic criterion for headache disorders) [6] Different 
types of non-specific NP are subdivided on the basis of 
etiology into non-traumatic and traumatic (e.g. whiplash). 
Fracture, dislocation, neurological disorders and 
fibromyalgia associated with the neck were excluded from 
non-specific neck pain. Specific NP includes radicular pain 
(including WAD III), cervical disc prolapse pain, and facet 
joint pain. 
 Exclusions: Articles were excluded if they investigated 
NP with the following: a) trauma associated with fracture or 
head injury; b) definite or possible long tract neurological 
signs (e.g., myelopathies); c) NP caused by other 
pathological entities (e.g., tumours, infections); d) headache 
not of cervical origin but associated with the neck (e.g., 
migraine, tension-type headache). 
 
Types of Interventions in the Reviews and CPG 
 For SR evaluating the efficacy of treatment or harms 
associated with the treatment, the interventions were limited 
to manual therapy, physical medicine modalities, drug 
therapies, patient education and communication, ergonomics, 
Management of Neck Pain The Open Orthopaedics Journal, 2013, Volume 7    463 
orthoses, prevention, and psychological interventions. For 
SR evaluating treatment and harms, only reviews that had 
searched at least two bibliographic databases and had 
undertaken some form of assessment of risk of bias of the 
included studies were eligible; this restriction was not 
applied to the other clinical areas (prognosis, diagnosis, or 
outcomes). This approach is consistent with methods for 
OvR to ensure only the best evidence is included in the 
findings and to minimize duplication [5]. Exclusions: 
treatment SR published prior to 2005 that searched a single 
database, or did not undertake a risk of bias assessment. 
 Diagnostic tests considered in the OvR included clinical 
examinations, radiologic tests (i.e., X-ray, mylography, 
electro-diagnostics, CT, MRI, provocation discography), 
specialized clinical tests (i.e., ROM, muscle endurance and 
strength, palpation tests, provocation tests for nerve tissue, 
functional tests, non-organic signs), injections, laboratory 
tests, blood tests; no citation was excluded based on the 
types of diagnostic tests. Articles that attempted to evaluate 
different systems of NP classification systems, consensus 
processes or models, definitions, terminologies, or 
frameworks aimed at categorization of NP diagnoses or 
disorders were also eligible. Exclusions: None for diagnostic 
tests or classification systems of the neck. 
 For reviews evaluating the evidence for prognostic 
factors, any prognostic factor or predictor (i.e., accident 
parameters, biological factors, psychological factors, 
behavioral factors, symptoms or interference factors, 
medico-legal context factors, other social and demographic 
factors) of outcomes were eligible; studies evaluating 
primary risk factors for the onset of neck-related problems 
were excluded. Articles were not restricted by the type of 
outcome associated with the prognostic factor in patients 
with NP. Where described, outcomes were grouped 
according to those types that could be included within the 
general International Classification of Function (ICF) 
domains of body structure and function, activity limitation, 
restricted participation, and environmental factors. 
Exclusions: None for prognostic factors; SR of risk factors 
for developing NP were excluded. 
 For reviews evaluating outcome measures, publications 
that evaluated at least one of the psychometric/clinimetric 
properties (reliability, validity, responsiveness, cross-cultural 
validation, floor-ceiling effect, interpretability) of self-
reported or observed outcomes were eligible. There were no 
restrictions on the type of outcome measure evaluated within 
NP populations. Exclusions: None for type of outcome 
measure. 
Types of Publications and Language Restrictions for 
Reviews and CPG 
 Eligible publications included systematic or narrative 
reviews [7], other OvR, CPG or consensus statements or 
commentaries associated with NP. Treatment, harms, and 
prognosis areas were limited to SR only; diagnosis and 
outcomes allowed narrative reviews and commentaries 
related to the area being evaluated. SR are characterized by 
comprehensive methods to identify and synthesize all the 
literature on a given topic. A publication was considered to 
be a narrative review if it labeled itself as a review but did 
not clearly identify the methods for selecting relevant studies 
or synthesizing the evidence. All CPG and consensus 
statements that included recommendations or algorithms for 
the management of NP were eligible. Note that CPGs are 
defined as systematically developed statements to assist 
practitioner and patient decisions about appropriate health 
care for specific clinical circumstances; they can be 
developed by local, regional, national or international groups 
or affiliated governmental organizations. Consensus 
statements are similar; but reflect a different methodology 
for deriving recommendations. Algorithms are variable in 
how they present guidance and may reflect recommended 
pathways for treatment or diagnosis. 
Search Methods for Identification of Studies 
 A research librarian searched the following computerized 
bibliographic databases of the medical, chiropractic, and 
allied health literature, without language restrictions from 
January 2000 to March 2012: MEDLINE, EMBASE, 
CINAHL, ILC, and CENTRAL, and LILACS. References 
within eligible articles were screened for any additional 
references, as well as relevant publications from personal 
files of the investigative team. APPENDIX shows the search 
terms used for the OvR in MEDLINE. 
Data Collection and Analysis 
Selection of Studies 
 Screening of titles and abstracts focused on identifying 
the following: systematic or narrative reviews, other OvRs, 
CPGs or consensus statements associated with NP, in any of 
the five clinical areas (with exclusions as described above). 
Two screeners independently evaluated the titles and 
abstracts or full text articles from the computer searches 
using pre-piloted forms placed within Distiller software 
(copyright 2009). Disagreements were resolved through 
consensus in both stages of selection. If consensus could not 
be reached, a third rater (lead investigator) adjudicated the 
final rating. If the article or citation posting was in a 
language other than English, one investigator and a translator 
with a medical background conducted the study selection 
and extraction. 
Data Extraction and Synthesis 
 A single reviewer extracted primary fields related to the 
characteristics, main findings, risk of bias assessment, and 
strength of evidence evaluation in SR and quality of CPGs. 
Each of the primary authors then independently verified the 
extracted data and inconsistencies were resolved by 
consensus. The specific fields extracted are detailed in the 
individual summary papers (see this issue for some OvR in 
treatment, prognosis and outcomes). Generally, 
characteristics of the eligible reviews (and characteristics of 
the studies evaluated within the reviews) were extracted and 
included types of NP, types of interventions, diagnostic tests, 
prognostic factors, and outcomes. Qualitative syntheses were 
undertaken in each of the OvR for the five clinical areas of 
NP management; the potential for quantitative synthesis was 
evaluated separately for each area. Where possible, summary 
tables of the primary findings of each review were 
assembled and presented. Synthesis of SR and narrative 
reviews were summarized separately. 
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Assessment of Risk of Bias in Included SR and CPG 
 Two screeners applied the AMSTAR risk of bias tool for 
SR. This checklist has been shown to have good face and 
content validity for assessing methodological quality [8, 9]. 
The AMSTAR evaluates 11 criteria within SR that have the 
potential to introduce systematic bias. Some of the items 
considered within the AMSTAR tool include 
comprehensiveness of the search strategy (including grey 
literature), the degree to which characteristics of the primary 
studies are adequately presented, the method for assessing 
scientific quality of eligible studies, the appropriateness of 
methods used to synthesize studies, identification of 
publication bias, and conflict of interest. 
 CPG were evaluated using the AGREE II instrument [10] 
by two screeners. The AGREE II evaluates six domains that 
assess the process and rigour of CPG development. These 
included the domains of scope and purpose, stakeholder 
involvement, rigour of development, clarity of presentation, 
applicability, and editorial independence. Scores were 
summarized for each of these domains. The AGREE II has 
been shown to be a reliable and valid instrument to critically 
appraise guideline development [11]. 
Qualitative Analysis of the Strength of Evidence 
 Currently, no methods exist to evaluate the strength of 
evidence (SOE) for findings across different SRs. 
Approaches to assess SOE, such as GRADE, are currently 
used with primary studies from a single systematic review 
[12-18]. In general, GRADE criteria used to judge the 
primary studies within a SR include the study design, risk of 
bias; imprecision (sample size); inconsistency (direction and 
magnitude of results); indirectness (applicability to patient 
populations with NP); and reporting bias. 
 As such, our team developed an approach using the 
GRADE but adapted for SR (rather than primary studies) 
evaluating the efficacy of treatments and diagnostic tests. Where 
available the rating of SOE within each review for specific 
interventions were extracted; when a SOE rating was not 
reported, an attempt was made by investigators to rate this 
evidence using the GRADE approach. If more than one SR was 
eligible for one type of intervention (e.g. three SR on exercise 
and NP)) and only one provided a rating of SOE using the 
GRADE approach, then that SOE reported was the one that was 
extracted and reported (for all three SR in this example). When 
SR reported SOE using different systems, these were compared 
to those SR that did use the GRADE approach; any similarities 
or differences between SOE ratings in these reviews were 
compared and a final judgement was made for the specific 
intervention. When there were two or more SR evaluating the 
same intervention and that provided GRADE SOE ratings, then 
all ratings were extracted and reported. Attempts were made to 
reach a consensus with respect to a final rating for the SOE for 
each intervention. A qualitative summary of the SOE using the 
same domains (risk of bias, inconsistency, imprecision, 
indirectness, and publication bias) is presented for evaluating 
the overall quality of OvR for prognostic or outcome 
measurement studies; currently no guidelines are provided for 
prognostic or outcome type studies using the GRADE  
system. Magnitude and consistency of synthesized results across 
different SR teams provided the final SOE statement in these 
areas. For the CPG, the proportion achieving greater than 50% 
in each of the six domains within the AGREE II is used as the 
threshold to characterize the overall quality of the guidelines. 
RESULTS 
 Fig. (1) shows the flow of eligible articles for reviews 
evaluating all the clinical areas for NP management. When 
combined across the different areas of NP management, a 
total of 10,059 articles were found and from these, 7579 
were duplicates (75%). Articles from grey literature sources 
and personal files (n=101) are also shown in Fig. (1) and 
these were relevant primarily in the OvR of treatment and 
CPG. From 2480 initial articles (after duplicates were 
removed), 512 were screened at full text. Fig. (1) also shows 
the distribution of eligible articles with respect to the areas of 
management of NP; there was some overlap between clinical 
areas (for example, there were 12 articles that were eligible 
for both diagnosis and outcomes). This overlap is a reflection 
of the content of the publications containing information 
relevant to both areas. 
 Table 1 shows the number of duplicates amongst the 
different bibliographic databases and the yield for the 
different clinical areas that were searched. From these, the 
search for reviews of outcome measures yielded the smallest 
proportion of overlap when searching across different 
databases and the greatest overlap was in prognosis (54%). 
Relative Distribution of Literature on NP 
 Fig. (1) shows that the majority of eligible articles were 
for the clinical area of treatment (n=117) and the smallest 
number for harms and prognosis (n=16 each). Diagnostic 
tests also yielded a relatively large number of articles of 
which the majority were SR (44 from 54). When considering 
the reasons for exclusion at full text, the majority of 
excluded articles were treatment reviews published prior to 
2005 (n=103). Similarly, a large number of articles that 
evaluated chronic pain management for musculoskeletal 
disorders did not have sufficient (greater than 50% studies 
on NP) or stratified data for NP and were excluded (n=73). 
Fig. (1) shows other reasons for exclusion at full text. It was 
anticipated that some areas of NP management would not be 
well indexed or have few SR. As such, narrative reviews and 
commentaries were eligible for diagnosis/classification, 
prognosis and outcomes. Although a large number of articles 
for diagnosis and classification (n=109) were eligible given 
the intentionally broad criteria during screening, the greatest 
proportion of articles were narrative reviews or 
commentaries on classification of neck disorders (n=55). 
However, a preliminary analysis of the articles for 
classification revealed a disparate set of publications that 
were not primarily focused on summaries or evidence for 
disease taxonomy. There was often overlap with other 
clinical areas and very little data to extract for classification. 
As such, these 55 articles are now excluded from this OvR 
(see Fig. 1). Table 1 shows that the OvR of diagnosis and 
outcomes included a small proportion of narrative reviews in 
their final inclusion that provided summary information on a 
specific diagnostic test or outcome measures. 
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Fig. (1). Flow Diagram of citations screened and eligible for this review of reviews. 
 
Table 1. Yield of Citations Across the Different Areas of NP Management 
 
 Treatment or Harms (%) Diagnosis and Classification Prognosis Outcome Measures 
Citation Yield 5056  1991 2518 490 
Duplicates across searched databases 2048 (41%) 836 (42%) 1371 (54%) 95 (19%) 
Interim Yield Tx-SR =113 
Hx-SR = 16 
109  
(SR = 44/ NRO = 65) 
SR = 16 27  
(SR = 13/ NRO = 14) 
Final Yield Tx-SR = 113 
Hx-SR = 16 
SR /NRO = 54 SR = 16 SR/NRO = 27 
Tx = treatment; Hx = Harms; SR = systematic review; NRO = narrative reviews 
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Risk of Bias 
 Figs. (2, 3) compare the criteria for AMSTAR across the 
areas of NP management. AMSTAR scores for each 
individual area of NP management are shown in web 
APPENDIX (Figs. 1-5). There were three criteria where 
generally all clinical areas were at high risk of bias (Fig. 2). 
A specific conflict of interest statement (AMSTAR Q11) 
was predominately absent (88% to 100% of SRs) in all areas 
of NP management. 
 Assessment of publication bias (AMSTAR Q10) was also 
absent in most areas of NP management (96% to 100% of 
reviews). Similarly, the majority of SR did not report the list 
of excluded studies (AMSTAR Q5) (61% to 94%) or used 
the publication status as an inclusion criteria (AMSTAR Q4) 
(43% to 92%). With the exception of treatment articles 
(56%), SR in the other clinical areas employed “duplicate” 
selection and data extraction of eligible studies (AMSTAR 
Q2) infrequently (25% to 46%). 
 In contrast, all areas of NP management scored well on a 
priori specification of the protocol (AMSTAR Q1) (88% to 
100%) (Fig. 3). With the exception of the areas of prognosis 
(57%), all other areas generally undertook a comprehensive 
search (AMSTAR Q3) (80% to 100%). Generally, assessment 
of the risk of bias (AMSTAR Q7) and appropriate use of this 
in the formulation of conclusions (AMSTAR Q8) was 
achieved fairly well in the treatment and prognosis SR 
(89/85% to 93/86%); this was less consistently undertaken in 
the areas of diagnosis, outcomes, or harms (54% to 57%). 
Note that the AMSTAR does not assess the merits of the 
various methods used to assess risk of bias of the primary 
studies included in each SR. With the exception of diagnostic 
and outcome reviews (46% to 69%), the SR in the other three 
clinical areas adequately described the characteristics of 
included studies (AMSTAR Q6) (81% to 86%). 
 Meta-analyses were rarely undertaken in (AMSTAR Q9) 
the SR and as such most areas (68% to 100%) received a 
‘not applicable’ rating for methods used to combine studies 
(even in SR of treatment). The reporting within the reviews 
was sufficiently ambiguous that it could not be determined if 
the studies undertook duplicate study selection and 
extraction (AMSTAR Q2) from 10% to 12% for treatment 
and harms and 20% to 23 % in the other areas. 
Fig. (2). Areas of neck pain management and AMSTAR scores indicating high risk of bias for these domains. 
Fig. (3). Areas of neck pain management and AMSTAR scores indicating low risk of bias for these domains. 
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DISCUSSION 
 This paper describes the methods used to undertake a 
comprehensive OvR to evaluate the evidence in the five key 
areas in the management of NP. The motivation in 
undertaking an OvR was to efficiently summarize the state 
of the evidence across a large literature base that addresses 
the major aspects of management of NP. Since an OvR 
serves to provide a high-level or panorama view of the 
literature in a specific area [19] comparisons across clinical 
areas is ideal; as such, the relative amount of literature and 
overlap across clinical areas, as well as any differences in 
AMSTAR scores risk of bias were evaluated in this OvR. 
The specific findings of the OvR within each clinical area of 
NP management are presented elsewhere. 
 There are some potential limitations to the approach 
taken in the methods employed in this OvR. When 
considering threats to validity of OvR, several issues have 
been identified in the literature. There is some potential risk 
for selective outcome reporting even in OvR and therefore a 
priori specification of the outcomes within the OvR would 
be recommended [20]. The methodologies in this OvR did 
not restrict SR based on the outcomes reported in any of the 
five clinical areas; however, within each specific clinical 
area, there was some variation in which outcomes were 
reported; this challenge is similar to differences across 
primary studies summarized within SR. Experience with 
OvR including only Cochrane SR have suggested greater 
attention to reporting findings based on the outcome (rather 
than the intervention) to facilitate interpretation [20]. 
Although there are no specific recommendations in the 
literature for assessing SR of diagnosis, harms, prognosis, or 
outcomes, this suggestion may be equally applicable to these 
areas. 
 Another issue that may affect validity of the OvR 
findings concerns the recency of the eligible SR; if reviews 
are not up to date, then the validity of the results are 
compromised. Our search commenced in 2000, and captures 
approximately a 12 year interval; an interval greater than five 
years was selected, as it was anticipated that some types of 
interventions, diagnostic tests, or CPG would not have had a 
summary evaluation in this timeframe. For the articles 
evaluating treatment interventions, the overwhelming 
number of SR available necessitated re-evaluation of the 
time interval and as such the eligible articles were restricted 
to the last five years only. This approach would be consistent 
with those proposed by Whitlock et al. (2008)[5] who 
recommend the selection of SR that are the most 
chronologically recent and at the lowest risk of bias. The 
prognostic SRs were limited to those published in the 
previous 10 years (back to 2002), since many of the primary 
papers were included in multiple SRs, and inclusion of the 
previous 10 years provided ample saturation of this 
literature. In order to include all relevant interventions, 
clinical tests, harms, or outcomes used to manage NP, SR 
with publication dates prior to 2005 were included. It can be 
reasoned that less current evidence (older than 5 years) is 
preferable to presenting none; the lack of updates in any 
specific clinical area serves as good indicator of where future 
research efforts could be directed. 
 
 Other general issues when undertaking OvR concern 
potential difficulties in combining findings from different 
meta-analyses estimated in the original SR; however, none of 
the specific clinical area OvR undertook computations of an 
overall summary estimate. Although methods to summarize 
evidence across SR in OvR have been established [1,5], there 
are variations in approaches used that have been identified in 
the literature [21, 22]. Most notably, some OvR have not 
assessed risk of bias in the original SR, or addressed 
discrepancies between SR. Methods of addressing discordance 
amongst reviews were not specified a priori, but in general 
explanation of differences in direction and magnitude of 
effects, and differences in methodologies within the SR were 
noted as previously specified [23]. The methods employed in 
this OvR have been explicitly described and eligible SR have 
been assessed for risk of bias and reporting of findings 
attempted to comply with reporting standards for systematic 
reviews, albeit not developed for OvR [24]. 
 Additionally, the development of our SOE approach 
required some a posteriori consensus for assigning a level of 
evidence when one was not provided or provided in a system 
other than GRADE. An adaptation of the GRADE system 
was undertaken where the same domains (risk of bias, 
inconsistency, indirectness, imprecision, and publication 
bias) were considered in the general sense for SR. OvR 
conducted within the Cochrane Collaboration recommend 
the reporting of methods used to determine SOE within 
eligible SR [20]. However this task is relatively simple in 
Cochrane reviews as standardization of reporting SOE are 
based on the GRADE. The limitations to the approach for 
extracting and summarizing SOE used in this OvR are not 
yet known, but have face validity. 
Yield and Overlap Among the Areas of NP 
 Our yield of articles across the different clinical areas 
shows a significant gap with respect to areas of inquiry on 
the management of NP. This search of reviews showed a 
primary focus of all publications to be on treatment of neck 
pain and to a lesser extent for diagnostic tests; the numerous 
treatments and clinical tests may in part account for this. The 
majority of CPG also focused on treatment 
recommendations, with a lesser emphasis on diagnostic tests. 
In contrast, relatively few SR evaluated the potential for 
harms, prognostic factors, or the use or properties of 
outcome measures. Previous research [25, 26]. would 
suggest a different distribution of literature across the 
clinical areas, with studies on risk factors and treatment for 
neck pain being most frequent; the area most infrequently 
assessed in this previous OvR was articles assessing 
economic costs. This previous research included 
predominately primary studies rather than SR. Owing to our 
purpose to use the results of these OvRs to inform clinical 
practice in all areas of NP management, we were not 
concerned with SRs of primary risk factors for the onset of 
new neck pain, rather our focus was on management, 
measurement and prognosis (secondary risk) of existing neck 
pain. Harms, outcome measures, and classification studies 
are novel additions of the current series of OvRs, having not 
been evaluated in the previous OvR. 
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 When considering duplication of articles across different 
bibliographic databases, it was surprising that the SR on 
outcome measures yielded the smallest proportion of 
overlap; this suggests that searching multiple databases are 
important for this clinical area of NP management. 
Additionally, there was a fair amount of overlap in articles 
across the different clinical areas. This may reflect a trend in 
assembling more comprehensive summaries addressing 
multiple areas, especially combined guidelines and best 
evidence syntheses. 
 The screening yielded a large number of articles for 
diagnosis and classification (n=109), and the greatest 
proportion were narrative reviews on classification of single 
or multiple NP disorders or syndromes (n=55). Our criteria 
for screening in classification-related articles were very 
broad and may have been a factor in this large number. 
However, a preliminary analysis of the articles for 
classification revealed a disparate set of publications that 
were not primarily focused on summaries or evidence for 
disease taxonomy. There was overlap with other clinical 
areas and very little data to extract for classification. This 
suggests that our search terms, which were limited to 
systematic and narrative reviews, were not sufficiently 
comprehensive. A review of primary studies may be required 
to adequately address the evidence for classification of NP. 
Diagnostic Tests versus Outcome Measures 
 There were a number of methodological issues that 
ensued while undertaking this OvR. One issue that required 
some a posteriori consensus concerned the definition of an 
outcome measure versus a clinical or diagnostic test. A 
traditional conceptualization of a diagnostic or clinical test 
was one that would assist in confirming the presence or 
absence of disease. However, recent conceptualizations of 
clinical tests have been expanded to broaden this scope, such 
that any process that is used to inform or change patient 
management can be regarded as a clinical test [27]. Clinical 
tests can be used to monitor disease changes, assess 
prognosis, and screen for presence of disease. Parallel to this 
is more recent definitions of an “outcome measure”, which 
defines the variety of outcomes as ones that provide clinical 
“endpoints” (that may include morbidity, health or functional 
status, mortality, and even laboratory values) [5]. The 
distinction between a diagnostic or clinical test and an 
outcome measure appears to be less clear. This is also 
evident in clinical practice where a clinical test can be used 
several times for different purposes. As an illustrative 
example, one might consider range of motion testing, where 
this is typically used to assess current mobility status at 
initial assessment (diagnose movement problems), it can also 
be used to monitor the impact of treatment, as part of a final 
assessment to indicate the end of treatment (outcome), or as 
a prognostic factor following traumatic neck injury. 
Similarly, the Neck Disability Index can be used to assess 
severity of functional limitations and be used by a clinician 
to stratify patients into prognostic groups or to inform 
selection of treatment options (based on these groupings), 
but it can also be used to assess the outcome of the 
treatment. Thus, the same clinical test/outcome measure can 
be used for assessment (or diagnostic) purposes, as well as 
for prognosis, classification, or measurement of treatment 
outcome (outcome measure). 
 From a practical perspective distinguishing where the 
eligible reviews should be categorized with respect to 
placement within the diagnostic, prognostic or outcome 
groups in some cases proved challenging. One attempt was 
to distinguish the aim of the review by the types of the 
analyses undertaken, but this too proved problematic. Often 
the eligible citation would evaluate a clinical test using 
traditional accuracy performance measures (i.e., sensitivity 
and specificity) and also clinometric characteristics 
(reliability, validity, responsiveness). Our attempt to resolve 
this classification dilemma was to include the articles in 
several of the clinical areas in consultation with the expert 
panel, many of whom had representation on the included 
SRs. Nonetheless, this overlap may serve to inflate the 
relative proportion of literature in these three areas and 
report findings in duplicate across the different clinical areas. 
CONCLUSIONS 
 We have provided a description of the methods used to 
undertake a comprehensive review of published SR across 
all areas of NP; this OvR captured relevant reviews 
involving treatment, harms, diagnosis, prognosis and 
outcomes for the management of NP. The challenges of 
selecting and synthesizing eligible articles in an OvR 
required customized solutions across different areas of 
clinical focus. Comparisons across the different areas of NP 
show that the greatest number of SR evaluated treatment 
interventions and the fewest outcome measures. Some 
differences in the risk of bias with individual SR across the 
different areas of NP were also noted; generally there were 
consistent problems with reporting potential conflict of 
interest, assessing publication bias, specification of excluded 
studies list, and inclusion of grey literature. Future SR could 
address the noted risk of bias deficiencies and the relative 
imbalances of knowledge for the different areas of NP 
management. 
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APPENDIX 
 
Fig. (1). AMSTAR scores for reviews evaluating treatment of NP. 
 
Fig. (2). AMSTAR scores for reviews evaluating harms of interventions used in NP. 
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Fig. (3). AMSTAR scores for reviews evaluating diagnostic tests used to assess NP. 
 
Fig. (4). AMSTAR scores for reviews evaluating prognostic indicators of NP. 
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